| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 366,402 | 388,249 | 369,565 | 380,398 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 366,402 | 388,249 | 369,565 | 380,398 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 340,268 | 370,775 | 385,463 | 397,229 | | Non Recurring |
-
|
-
|
-
| 4,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 26,134 | 17,474 | (15,898) | (20,831) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 26,134 | 17,474 | (15,898) | (20,831) | | Interest Expense | 4,751 | 4,843 | 5,024 | 5,036 | | Income Before Tax | 21,383 | 12,631 | (20,922) | (25,867) | | Income Tax Expense | 1,180 | (3,057) | (8,045) | (11,479) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 20,203 | 15,688 | (12,877) | (14,388) | | | Non-recurring Events | | Discontinued Operations | (7,196) |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,007 | 15,688 | (12,877) | (14,388) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $13,007 | $15,688 | ($12,877) | ($14,388) |
|
0.51% Nasdaq 
Income Statement
